Tag

#Skin Cancer Drug

1 post

News

FDA Commissioner Makary Defends Rejection of Replimune Cancer Drug

FDA Commissioner Dr. Marty Makary defends the agency’s decision to deny approval for Replimune’s advanced skin cancer treatment.

Charles D. Whitfield 19 hrs ago